ASX Announcements / Clinuvel Pharmaceuticals Limited (ASX:CUV)

All Clinuvel Pharmaceuticals Limited (ASX:CUV) announcement summaries, newest first. Every summary is drawn only from the company's official ASX release.

ASX: CUVHealth Care

Clinuvel Sets Vitiligo Benchmarks Before CUV105 Data

Clinuvel published peer reviewed vitiligo benchmarks for narrowband UVB and JAK inhibitors ahead of topline CUV105 results for SCENESSE due in December 2026.

30 Jul, 2026

ASX: CUVHealth Care

Clinuvel SCENESSE Vitiligo Topline Data Due Dec 2026

Clinuvel expects topline CUV105 results for SCENESSE in vitiligo in December 2026 and plans to start its pivotal Phase III CUV107 study in November 2026 abroad.

28 Jul, 2026